| Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784) |
|---|
| 04/27/2006 | DE102005049750A1 Immunological absorber for treating inflammations, comprises organic/synthetic polymer substrates, which is covalently bonded to poly/monoclonal antibodies are arranged against to the peptide complement factors and sepsis mediators |
| 04/27/2006 | DE102004051804A1 Beta-L-N4-Hydroxycytosin-Desoxynucleoside und ihre Verwendung als pharmazeutische Mittel zur Prophylaxe oder Therapie von viralen Erkrankungen Beta-L-N4-hydroxycytosine-deoxynucleosides and their use as pharmaceutical agents for the prophylaxis or therapy of viral diseases |
| 04/27/2006 | DE102004051025A1 Substituierte Nonadepsipeptide Substituted nonadepsipeptides |
| 04/27/2006 | DE102004051024A1 Heterocyclyl-substituierte Nonadepsipeptide Heterocyclyl-substituted nonadepsipeptides |
| 04/27/2006 | DE102004050283A1 4-Aminophenyl-morpholinon-Derivate und deren Herstellung 4-aminophenyl-morpholinone derivatives and their preparation |
| 04/27/2006 | DE102004040119A1 Agent, useful for e.g. inactivating infectious prion and decontaminating device, instrument or appliance infected with prion, comprises a nano-particle |
| 04/27/2006 | CA2584670A1 Combination therapy for treating viral infections |
| 04/27/2006 | CA2584209A1 Reversible inhibitors of s-adenosyl-l-homocysteine hydrolase and uses thereof |
| 04/27/2006 | CA2584207A1 Antiviral oligonucleotides |
| 04/27/2006 | CA2583943A1 Novel curcumin analogues and uses thereof |
| 04/27/2006 | CA2583900A1 Use of baff to treat sepsis |
| 04/27/2006 | CA2583576A1 Chimera (double) decoy |
| 04/27/2006 | CA2583152A1 Inhibitors of hepatitis c virus protease, and compositions and treatments using the same |
| 04/27/2006 | CA2576643A1 Screening assays for inhibitors of a staphylococcus aureus siderophore |
| 04/27/2006 | CA2574518A1 Pharmaceutical composition and non dependence coffee comprising edible carboxylic acid and/or its acid salt and coffeine |
| 04/26/2006 | EP1650310A1 Recombinant avian adenovirus vector |
| 04/26/2006 | EP1650309A1 Lentiviral vectors for the preparation of immunotherapeutical compositions |
| 04/26/2006 | EP1650225A1 Hetero type pentamer recombinant vaccine |
| 04/26/2006 | EP1650218A1 The artificial cpg single strand deoxidation oligonucleotide and its antiviral uses |
| 04/26/2006 | EP1650199A1 Sulfonamide derivative having isoxazole ring |
| 04/26/2006 | EP1650195A1 Method of inhibiting production of osteopontin |
| 04/26/2006 | EP1650193A2 6-Phenylphenanthridines with PDE-IV inhibiting activity |
| 04/26/2006 | EP1649871A1 Retroviral protease inhibitor combinations |
| 04/26/2006 | EP1649868A1 IL-12 as an adjuvant for Bordetella pertussis vaccines |
| 04/26/2006 | EP1649864A1 Periodontal disease therapeutic and/or preventive composition |
| 04/26/2006 | EP1648906A1 Organosilicon compounds and their use |
| 04/26/2006 | EP1648894A1 Method for the production of oh protected [4-(2.6-diamino-9h-purine-9-yl)- 1.3-dioxolane-2-yl]methanol derivatives |
| 04/26/2006 | EP1648889A1 Isethionate salt of a selective cdk4 inhibitor |
| 04/26/2006 | EP1648871A1 Piperidine or 8-aza-bicyclo 3.2.1 oct-3-yl derivatives useful as modulators of chemokine receptor activity |
| 04/26/2006 | EP1648513A2 Use of adcc-optimized antibodies for treating weak patients |
| 04/26/2006 | EP1648504A2 Adjuvant combinations of liposomes and mycobacterial lipids for immunization compositions and vaccines |
| 04/26/2006 | EP1648498A1 Microsome vaccine |
| 04/26/2006 | EP1648476A1 Mouth and/or throat wash |
| 04/26/2006 | EP1648473A1 Single dose fast dissolving azithromycin |
| 04/26/2006 | EP1648469A2 Antiglucocorticoids for the treatment of catatonia |
| 04/26/2006 | EP1648467A1 Process for preparing particles containing an antiviral |
| 04/26/2006 | EP1648449A2 Benzimidazole derivatives and their use as protein kinases inhibitors |
| 04/26/2006 | EP1648431A1 Novel use of a polyamine-poor composition for the production of a medical human food |
| 04/26/2006 | EP1648426A2 Benzimidazole derivatives and their use as protein kinases inhibitors |
| 04/26/2006 | EP1648419A1 Treatment of lesions of soft tissues |
| 04/26/2006 | EP1648418A2 Antibiotic product, use and formulation thereof |
| 04/26/2006 | EP1648415A2 Antibiotic product, use and formulation thereof |
| 04/26/2006 | EP1648407A2 Antibiotic product, use and formulation thereof |
| 04/26/2006 | EP1534708B1 Purine derivatives and their use as antiproliferative agents |
| 04/26/2006 | EP1421377B1 The natural ligand for orphan g protein coupled receptor gpr86 and methods of use |
| 04/26/2006 | EP1414802B1 Heteroarylheteroalkylamine derivatives and their use as inhibitors of nitric oxide synthase |
| 04/26/2006 | EP1402039B1 MUTANT FORMS OF EtxB AND CtxB AND THEIR USE AS CARRIERS |
| 04/26/2006 | EP1303286B1 Use of strains of the parapox ovis virus for producing antiviral pharmaceuticals and anticancer pharmaceuticals |
| 04/26/2006 | EP1218514B1 Designing immunogens |
| 04/26/2006 | EP1049788B1 Protein expression in baculovirus vector expression systems |
| 04/26/2006 | EP1002108B1 Use of mhc class ii ligands as adjuvant for vaccination and of lag-3 in cancer treatment |
| 04/26/2006 | EP0850305B1 Compounds and methods for diagnosis of tuberculosis |
| 04/26/2006 | CN1764723A Interleukin-18 mutants, their production and use |
| 04/26/2006 | CN1764655A Aromatic sulfone hydroxamates and their use as protease inhibitors |
| 04/26/2006 | CN1764653A FKI-1366 substance and its production |
| 04/26/2006 | CN1764649A Benzyl-pyridazinons as reverse transcriptase inhibitors |
| 04/26/2006 | CN1764645A Oxamide derivatives useful as raf-kinase inhibitors. |
| 04/26/2006 | CN1764641A Viral polymerase inhibitors |
| 04/26/2006 | CN1764473A Use of alum and a Th1 immune response inducing adjuvant for enhancing immune responses |
| 04/26/2006 | CN1764468A Skin protecting composition |
| 04/26/2006 | CN1764450A Crystalline N-formyl hydroxylamine compounds |
| 04/26/2006 | CN1764432A Gargle for treating or preventing bacterial infection and fungus infection |
| 04/26/2006 | CN1763106A Antiviral fusion protein and its coding gene and uses |
| 04/26/2006 | CN1763105A Fusion protein for stimulating organism to produce FMDV antibody and its coding gene and uses |
| 04/26/2006 | CN1763096A Animal composite immune globulin production method |
| 04/26/2006 | CN1763092A Antibiotic peptide and its coding sequence and uses |
| 04/26/2006 | CN1763089A C-terminal amino acid lactone modified extrasin alpha-1 and its uses |
| 04/26/2006 | CN1763087A Towel gourd seed ribosome deactivated protein and its coding gene and uses |
| 04/26/2006 | CN1763086A ANK protein for controlling fungus colony growth and pathogenicity and its coding gene and utilization |
| 04/26/2006 | CN1763081A Antibiotic dipeptide and its chemical modifier, its preparation method and uses |
| 04/26/2006 | CN1763040A Abacavir production method |
| 04/26/2006 | CN1763018A Oxazolidinone analog compound |
| 04/26/2006 | CN1763002A Small molecular inhibiting agent for coronavirus main proteinase, its preparation method and uses |
| 04/26/2006 | CN1762967A Enoxolone derivative, preparation method and uses |
| 04/26/2006 | CN1762951A Compounds for the suppression of HIV TAT transactivation |
| 04/26/2006 | CN1762498A Use of new castle disease virus infected genome |
| 04/26/2006 | CN1762491A Use of BCG as adjuvant of active protein activating cytotoxic T-lymphocyte |
| 04/26/2006 | CN1762484A Bolus for treating hepatitis A, hepatitis B, chronic hepatitis and preparation method thereof |
| 04/26/2006 | CN1762482A Antivirus effervescence tablet |
| 04/26/2006 | CN1762475A Effervescence tablet for wind-cold type cold |
| 04/26/2006 | CN1762462A Chinese medicinal formulation for treating children's cold and its preparation method |
| 04/26/2006 | CN1762461A Rhubarb lyophilized injection and preparation method thereof |
| 04/26/2006 | CN1762448A Chinese herbal preparation for killing fungus of fish, shrimp and crab |
| 04/26/2006 | CN1762431A Giant knotweed pills formula and its preparation method |
| 04/26/2006 | CN1762429A Forsythia fruit pills formula and its preparation method |
| 04/26/2006 | CN1762406A Quality control method of ixeris sonchifolia injection |
| 04/26/2006 | CN1762388A Tasty, refreshing, sterilizing, yin-nourishing health care product or drug formula and preparation method thereof |
| 04/26/2006 | CN1762387A Aquaculture creature disease controlling compound vaccine and its preparation method |
| 04/26/2006 | CN1762377A Medicinal composition containing zidovudine, valproic acid or its salt |
| 04/26/2006 | CN1762376A Whitening acne-removing cream |
| 04/26/2006 | CN1762365A Beta-carotene clathrate and its preparation method |
| 04/26/2006 | CN1762363A Arteannuin pills formula and its preparation process |
| 04/26/2006 | CN1762358A Moxifloxacin capsule and its preparation method |
| 04/26/2006 | CN1762357A Oral medicinal formulation of moxifloxacin and its preparation method |
| 04/26/2006 | CN1762339A Contraceptive, sterilizing, virus-inhibiting medicine |
| 04/26/2006 | CN1762334A Medicinal cooling emulsions |
| 04/26/2006 | CN1253528C Desiccation compositions containing hydrophobic amino acid |
| 04/26/2006 | CN1253464C Ansi glycoside compound and its medicinal composition, preparation and use |
| 04/26/2006 | CN1253457C Crystals of penicillin and process for the production thereof |
| 04/26/2006 | CN1253452C Thioether subsituted imidazoquinoline compound |